Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New alphavbeta6 integrin inhibitors and their use described by Merck KGaA

Sep. 30, 2003

Novel muscarinc M2 agonists with potential utility in cardiovascular disorders

Sep. 30, 2003

Novel sodium channel blockers covered by Boehringer Ingelheim patent

Sep. 29, 2003

Na+/H+ exchange inhibitors identified by Aventis researchers

Sep. 29, 2003

Cardioprotective effects described for pexelizumab after acute myocardial infarction

Sep. 29, 2003

French authorities recommend against approval of Remodulin

Sep. 26, 2003

Carvedilol safe and effective in heart failure patients with Chagas' disease

Sep. 26, 2003

Tezosentan: effects on BNP and hemodynamics in acute decompensated heart failure

Sep. 26, 2003

Conivaptan effects on exercise tolerance in patients with chronic heart failure

Sep. 26, 2003

Beneficial effects of eplerenone in AMI patients with low LVEF

Sep. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...